

| Revenue | Over $500 million See Exact Annual Revenue |
|---|---|
| Employees | N/AExact Company Size |
| Primary Industry | 325411 Medicinal & Botanical Manufacturing |
| Additional NAICS Codes | 325412 Pharmaceutical Preparation Manufacturing 5417 Scientific Research & Development Services |
| Address | 65 Hayden Avenue Lexington, MA 02421 |
| Cubist Pharmaceuticals | Revenue Est. ($ Million) | Growth Rate (%) | # Employees |
|---|---|---|---|
| 2025 | Over $500 million Details in Premium Report | ||
| 2024 | |||
| 2023 | |||
| 2021 | |||
| 2020 | |||
| 2019 | |||
|
1-Year Growth Rate: 3-Year Growth Rate (CAGR): | ![]() |
| Cubist Pharmaceuticals P&L | $ Millions |
|---|---|
| Revenue (Sales) | ![]() |
| Cost of Goods Sold | |
| Gross Profit | |
Operating Expenses | |
| Advertising | |
| Salaries and wages | |
| Other Operating Expenses | |
| Total Operating Expenses | |
| Operating Income | |
| EBITDA | |
| EBIT (Earnings Before Interest and Taxes) | |
| Net Profit | |
| Trademark | Date |
|---|---|
| CASES COLLABORATIVE ANTIMICROBIAL STEWARDSHIP EDUCATION SYMPOSIA Educational services, namely, providing symposia and lectures in the medical and health care fields | 10/23/2014 |
| CUBIST CARES Charitable services, namely, patient assistance program to provide medical insurance copay assistance to eligible patients to reduce the cost of therapy; Providing patients who have been prescribed a course of therapy that involves prescription pharmaceuticals with information on medical insurance coverage, patient reimbursement options and financial support for that therapy | 04/07/2014 |
| ACCESS CUBICIN Charitable services, namely, patient assistance program to provide medical insurance copay assistance to eligible patients to reduce the cost of therapy; Providing patients who have been prescribed a course of therapy that involves prescription pharmaceuticals with information on medical insurance coverage, patient reimbursement options and financial support for that therapy | 04/07/2014 |
| Company | Headquarters | Revenue ($ MM) |
|---|---|---|
| XYMOGEN | Orlando, FL | 100 |
| AVANTI NUTRITIONAL LABORATORIES | Miami Lakes, FL | 37 |
| NUTRITION FORMULATORS | Miramar, FL | 36 |
| RTPR | Cabot, AR | 33 |
| INTEGRATED BOTANICS | Fort Worth, TX | 29 |
| COSMAX NBT USA | Garland, TX | 29 |
| CJB INDUSTRIES | Valdosta, GA | 28 |
| ALTERNATIVE LABORATORIES | Naples, FL | 28 |
| S&B PHARMA | Azusa, CA | 28 |
| Company | Headquarters | Revenue ($ MM) |
|---|---|---|
| REPLIGEN | Waltham, Massachusetts,united States, MA | 100 |
| APELLIS PHARMACEUTICALS | Waltham, MA | 67 |
| CUBIST PHARMACEUTICALS | Lexington, MA | 59 |
| BIOVERATIV U.S. LLC. | Waltham, MA | 58 |
| ABCAM | Waltham, MA | 29 |
| KARYOPHARM THERAPEUTICS | Newton, MA | 25 |
| Company | Headquarters | Revenue ($ MM) |
|---|---|---|
| ACCENT THERAPEUTICS | Lexington, MA | 100 |
| CONCERT PHARMACEUTICALS | Lexington, MA | 99 |
| Company | Revenue ($ MM) |
|---|---|
![]() | |